Oncternal Therapeutics Inc (NASDAQ:ONCT)
| 0.3031 Delayed Data As of 3:55pm ET |  +0.0047 / +1.58%Today’s Change | 0.26 Today|||52-Week Range 1.62 | -69.69% Year-to-Date |
Latest ONCT News | Press Releases
No recent news for Oncternal Therapeutics Inc.
Today’s Trading
| Previous close | 0.30 |
| Today’s open | 0.30 |
| Day’s range | 0.30 - 0.30 |
| Volume | 3,120 |
| Average volume (3 months) | 430,251 |
| Market cap | $17.7M |
Data as of 3:55pm ET, 06/02/2023
Growth & Valuation
| Earnings growth (last year) | -32.19% |
| Earnings growth (this year) | +23.69% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | -65.47% |
| P/E ratio | NM |
| Price/Sales | 35.30 |
| Price/Book | 0.28 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MBRXMoleculin Biotech In... | +0.04 | +6.48% |
| ZYNEZynerba Pharmaceutic... | +0.02 | +5.33% |
| ---- | ||
| TPSTTempest Therapeutics... | +0.05 | +3.47% |
Data as of 3:59pm ET, 06/02/2023
Financials
| Next reporting date | August 10, 2023 |
| EPS forecast (this quarter) | -$0.17 |
| Annual revenue (last year) | $1.5M |
| Annual profit (last year) | -$44.2M |
| Net profit margin | -2,964.43% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
